Pericardial Histopathology and COVID-19 Seropositivity Read more about Pericardial Histopathology and COVID-19 Seropositivity
Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO). Read more about Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).
Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers Read more about Phase 1 Study on Bioavailability, Food Effect, and Drug-Drug Interaction of ALG-097558 Tablets in Healthy Volunteers
Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC Read more about Expanded Access Program of Neladalkib (NVL-655) for Patients With Advanced ALK+ NSCLC
GemVax & KAEL Co. Ltd. By jpalfreyman on Fri, 04/25/2025 - 09:34 Read more about GemVax & KAEL Co. Ltd.
Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation Read more about Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation
Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Post COVID-19 Read more about Autologous Adipose-derived Stromal Vascular Fraction for Treatment of Post COVID-19
Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety Read more about Coronavirus Disease of 2019 (COVID-19) Health Education Initiative for School Safety
Frontier Medicines Corporation By jpalfreyman on Tue, 04/22/2025 - 14:19 Read more about Frontier Medicines Corporation
Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC Read more about Dalpicilib Plus Cetuximab Compared With Cetuximab Alone in HPV-negative, Anti-PD-1-resistant R/M HNSCC